Mr. Speaker, having an appropriate level of regulatory oversight for compounding-like activities is a priority for our government.
Health Canada acted quickly following the reported under-dosing of certain chemotherapy drugs in Ontario and has taken on a leadership role in facilitating the development of a long-term solution for all of Canada.
Health Canada issued an interim directive to facilities undertaking admixing and compounding activities and outlined the conditions under which they could be allowed to continue providing those services.
The department continues to work with provinces, territories, and other stakeholders to develop a collaborative approach to increase patient safety and to ensure that an appropriate level of regulatory oversight is in place for compounding-like activities.